BioArctic AB (BRCTF)
35.00
0.00 (0.00%)
USD |
OTCM |
Jun 09, 16:00
BioArctic Total Liabilities (Quarterly) : 50.51M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 50.51M |
| December 31, 2025 | 65.97M |
| September 30, 2025 | 67.18M |
| June 30, 2025 | 30.81M |
| March 31, 2025 | 18.83M |
| December 31, 2024 | 19.62M |
| September 30, 2024 | 17.21M |
| June 30, 2024 | 19.13M |
| March 31, 2024 | 13.43M |
| December 31, 2023 | 13.84M |
| September 30, 2023 | 10.45M |
| June 30, 2023 | 8.569M |
| March 31, 2023 | 6.708M |
| December 31, 2022 | 6.916M |
| September 30, 2022 | 6.143M |
| June 30, 2022 | 9.235M |
| March 31, 2022 | 10.91M |
| December 31, 2021 | 12.04M |
| September 30, 2021 | 14.64M |
| June 30, 2021 | 15.10M |
| Date | Value |
|---|---|
| March 31, 2021 | 14.62M |
| December 31, 2020 | 17.41M |
| September 30, 2020 | 17.42M |
| June 30, 2020 | 17.11M |
| March 31, 2020 | 16.57M |
| December 31, 2019 | 22.31M |
| September 30, 2019 | 25.26M |
| June 30, 2019 | 29.72M |
| March 31, 2019 | 30.52M |
| December 31, 2018 | 42.33M |
| September 30, 2018 | 39.33M |
| June 30, 2018 | 45.50M |
| March 31, 2018 | 54.58M |
| December 31, 2017 | 61.60M |
| September 30, 2017 | 67.00M |
| June 30, 2017 | 68.12M |
| March 31, 2017 | |
| December 31, 2016 | 71.24M |
| September 30, 2016 | 1.513M |
| June 30, 2016 | 1.556M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Hansa Biopharma AB | 150.89M |
| Swedish Orphan Biovitrum AB | 4.291B |
| Diamyd Medical AB | 9.292M |
| BONESUPPORT HOLDING AB | 18.89M |
| BioInvent International AB | 10.06M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 281.25M |
| Shareholders Equity (Quarterly) | 230.74M |
| Debt to Equity Ratio | 0.0185 |
| Current Ratio | 6.538 |
| Net Debt Paydown Yield | 0.00% |